ZNF222 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.776840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.156600E-01
Normal-vs-Stage2
1.228600E-01
Normal-vs-Stage3
2.944400E-01
Normal-vs-Stage4
5.946800E-01
Stage1-vs-Stage2
1.536350E-01
Stage1-vs-Stage3
3.694400E-01
Stage1-vs-Stage4
8.784800E-01
Stage2-vs-Stage3
8.562200E-01
Stage2-vs-Stage4
3.277200E-01
Stage3-vs-Stage4
4.200000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.653380E-01
Normal-vs-AfricanAmerican
3.288400E-01
Normal-vs-Asian
3.732800E-01
Caucasian-vs-AfricanAmerican
8.479800E-01
Caucasian-vs-Asian
7.975200E-01
AfricanAmerican-vs-Asian
9.977000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.897610E-01
Normal-vs-Female
1.801840E-01
Male-vs-Female
5.965800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.839000E-01
Normal-vs-Age(41-60Yrs)
4.323600E-01
Normal-vs-Age(61-80Yrs)
1.216370E-01
Normal-vs-Age(81-100Yrs)
2.231700E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.685200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.776800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.221600E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.601700E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.503000E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.573200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.670260E-02
Normal-vs-Daily Drinker
6.531800E-02
Normal-vs-Weekly Drinker
4.840200E-02
Normal-vs-Occasional Drinker
4.372400E-01
Normal-vs-Social Drinker
1.857650E-01
Non Drinker-vs-Daily Drinker
7.395200E-01
Non Drinker-vs-Weekly Drinker
7.933200E-01
Non Drinker-vs-Occasional Drinker
4.095600E-03
Non Drinker-vs-Social Drinker
2.068200E-01
Daily Drinker-vs-Weekly Drinker
9.650600E-01
Daily Drinker-vs-Occasional Drinker
2.910100E-02
Daily Drinker-vs-Social Drinker
4.152400E-01
Weekly Drinker-vs-Occasional Drinker
3.464300E-02
Weekly Drinker-vs-Social Drinker
4.120800E-01
Occasional Drinker-vs-Social Drinker
2.292200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.881820E-01
Normal-vs-Grade 2
6.726000E-02
Normal-vs-Grade 3
1.056380E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.498200E-01
Grade 1-vs-Grade 3
2.788600E-01
Grade 1-vs-Grade 4
1.881820E-01
Grade 2-vs-Grade 3
7.061800E-01
Grade 2-vs-Grade 4
6.726000E-02
Grade 3-vs-Grade 4
1.056380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.137600E-02
Normal-vs-NonDiabetic
2.052400E-01
Diabetic-vs-NonDiabetic
1.173940E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.818000E-02
Normal-vs-NoPancreatitis
1.453810E-01
Pancreatitis-vs-NoPancreatitis
2.577600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.088600E-01
Normal-vs-N1
1.139000E-01
N0-vs-N1
1.593810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.791420E-01
Normal-vs-TP53-NonMutant
2.874800E-01
TP53-Mutant-vs-TP53-NonMutant
7.937800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
